Analyst Ratings for Galena Biopharma (GALE)

GALE Rating Summary

GALE Price Target Summary

* Over Last 12-Mos
  |   Expand Research on GALE
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: $6.33 (+249.9%) * Over Last 12-Mos
Rating Score: 8.6 / 10
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
2/18/2014 Cantor Fitzgerald
» Updated 3/18/2014
Downgrade Sell
(Hold)
3.00
(3.50)
3.73 1.81 -51.47% Details
11/26/2013 Oppenheimer New Coverage Outperform
(N/A)
6.00
(N/A)
3.67 1.81 -50.68% Details
Like GALE Ratings? Also take a look at PBYI, CYTR, ACT, VSTM

GALE Ratings News